World news –JP-[Sale] Eisai (4523) Alzheimer’s drug dark clouds ◆ Asunaro Investment Advisor CEO Yasushi Oishi ◆ Posted: 2020/11/09 09:05 [Yasushi Oishi] –Minkabuja

0
12

[Caution] The information on « buy » and « sell » in « Minna no Kiso » is based on the personal opinion of the poster. However, we do not guarantee the authenticity of the information or the accuracy or reliability of the stock valuation. In addition, Tokyo Stock Exchange, Nagoya Stock Exchange, China Investment Information Services, NASDAQ OMX, CME Group Inc., Tokyo Commodity Exchange, Osaka Dojima Commodity Exchange, S&P Global, S&P Dow Jones Indices, Hang Seng Indexes, bitFlyer, NTT Data Avic, ICE Data Services, etc. The copyright of the Nikkei Stock Average belongs to Nikkei Inc. The information contained in « Minna no Kiso » is intended to provide information on investment in general as a reference for investment decisions, and is not intended to solicit investment. Although this information may contain forecasts regarding future business results and events, these statements are only forecasts and do not guarantee the accuracy or reliability of the contents. The Company, posters and information providers are not responsible for any damages incurred based on this information. All investment decisions are at your own discretion. If it is determined that an individual post violates the Financial Instruments and Exchange Act, etc., please provide the information to the Securities and Exchange Surveillance Commission from « Providing Information to the Securities and Exchange Surveillance Commission ». In addition, regarding the information published in « Minna no Kiso », it is firmly decided to divert, copy, sell, process, reuse and redistribute the information for the purpose of providing it to third parties as well as using it for sales. Forbid.

Eisai, Food and Drug Administration, Biogen

World news –JP-[Sale] Eisai (4523) Dark clouds in Alzheimer’s medicine ◆ Asunaro Investment Advisor CEO Yasushi Oishi / 11/09 09:05 [Yasushi Oishi] –Everyone’s stock (Minkabu)
Related title :
[ Selling] Eisai (4523) Alzheimer’s drug dark cloud Asunaro Investment Advisor CEO Yasushi Oishi
US FDA Advisory Board examines Aducanumab Most opinions that evidence is insufficient Approval by March
Biogen The plunge in stocks is also judged by the FDA Advisory Board on Alzheimer’s drugs
-<a href="/?s= Eisai sells FDA advisory board, negative for dementia drug effectiveness « > Eisai sells FDA advisory committee, negative for dementia drug effectiveness ja


SOURCE: https://www.w24news.com

QU’EN PENSEZ-VOUS?

Donnez votre point de vue et aboonez-vous!

[gs-fb-comments]

Votre point de vue compte, donnez votre avis

[maxbutton id= »1″]